We figured out we can fix our policies. Now we're rolling it all back.
In the years following a pandemic that made racial health disparities impossible to ignore, Boston's medical institutions built something rare: a body of research and practice designed to meet the most vulnerable where they live. Now, through NIH funding cuts and federal anti-DEI mandates, the Trump administration is systematically dismantling that infrastructure — not because the disparities have healed, but because the political will to name them has collapsed. What is at stake is not merely a budget line, but the continuity of a generation of scientists and the communities whose lives depend on the questions they were trained to ask.
- A 23-year life expectancy gap still separates Boston's wealthiest and poorest neighborhoods, and the federal government is cutting the research designed to close it.
- NIH grants targeting health equity are being terminated mid-study, forcing researchers to strip equity language from their own papers just to survive the political climate.
- Hospitals are quietly scrubbing gender-affirming care information from public websites, and media teams that once championed equity breakthroughs are now refusing all press inquiries on the subject.
- Local leaders like Dr. Bisola Ojikutu are vowing to press forward with city resources, but experts warn that no municipal budget can replace the scale of federal scientific infrastructure.
- The deeper loss may be generational — NIH funding doesn't just pay for studies, it pays for the student researchers who conduct them, and without it, an entire cohort of health equity scientists may never fully form.
When COVID-19 swept through Massachusetts in 2020, it moved along the familiar lines of race and poverty. Black residents died at higher rates. Latino communities were hit harder. Indigenous people disappeared into statistical catch-all categories that made their suffering nearly invisible. The crisis demanded a response, and for a time, it received one.
Massachusetts became a testing ground for equity-centered medicine. Researchers brought testing and treatment directly into underserved neighborhoods. State officials worked to disaggregate data so that Indigenous residents would no longer vanish into an "other" category. Programs like UMass Chan's Home Test to Treat extended care to Americans with little access to traditional health systems. These were not abstract initiatives — they were built on the understanding that protecting the most vulnerable protects everyone.
Then the political ground shifted. The Trump administration began cutting NIH funding for research tied to diversity, equity, and inclusion, while threatening universities with broader federal funding losses if they maintained DEI programs. A White House spokesperson framed the rollback as a matter of priorities, suggesting equity work and rigorous science are somehow in competition — a distinction that researchers on the ground flatly reject.
The effects are already tangible. An epidemiology instructor at Harvard lost the final third of a $228,000 NIH grant studying the pandemic's toll on sexual minorities' mental health. Researchers across Boston are rewriting papers to remove equity-focused language. Hospitals have quietly pulled gender-affirming care information from their websites. Communications teams that once celebrated equity breakthroughs now decline all press requests.
The disparities that prompted this work have not gone anywhere. Boston still carries a 23-year life expectancy gap between Back Bay and Roxbury. Black, Latino, Indigenous, and LGBTQ+ communities continue to face higher rates of chronic illness and COVID-related death. Some local officials have pledged to sustain the work with city resources, but others are sounding a longer alarm: federal funding doesn't just support studies — it supports the student researchers who conduct them, building the next generation of scientists equipped to ask the questions marginalized communities most need answered. Without it, that knowledge doesn't pause. It disappears.
The pandemic revealed something Boston's medical establishment had long known but struggled to act on: disease does not kill equally. When the coronavirus swept through Massachusetts in 2020, infection rates and death rates followed the contours of race, neighborhood, and access to care. Black residents died at higher rates than white residents. Latino communities were hit harder. Indigenous people, lumped into statistical obscurity on state dashboards, bore a burden no one could properly measure. The moment seemed to demand action, and for a time, it got it.
Massachusetts became something of a laboratory for equity-centered medicine. Researchers designed programs to meet patients where they lived. Hospitals brought testing and treatment to the neighborhoods that needed them most. The state's COVID-19 health equity advisory group worked to disaggregate data so that Indigenous residents would no longer disappear into an "other" category. Dr. Apurv Soni at UMass Chan Medical School created Home Test to Treat, an at-home COVID program for vulnerable Americans with spotty access to traditional health care. These were not abstract policy papers. They were interventions built on the recognition that protecting marginalized communities protects everyone.
Then the political ground shifted. The Trump administration began systematically dismantling the infrastructure that had enabled this work. The National Institutes of Health slashed funding for research studies deemed to advance diversity, equity, and inclusion. The Department of Education threatened universities with federal funding cuts if they did not eliminate their DEI initiatives. White House spokesperson Kush Desai framed the rollback as necessary: finite resources, he said, cannot be spent on "vague social goals" when they could fund "cutting-edge research" instead—a distinction that assumes equity work and rigorous science are somehow separate things.
The consequences are already visible. Ariel Beccia, an epidemiology instructor at Harvard's Chan School of Public Health, was studying the pandemic's impact on sexual minorities' mental health through an NIH grant worth roughly $228,000. The last third of that funding was terminated. Researchers across Boston are now rewriting papers to scrub mentions of health equity, antiracist frameworks, and demographic analysis—the very language that allowed them to see and address disparities in the first place. Some hospitals have removed details about gender-affirming care from their websites, not because the care stopped, but because publicizing it has become politically risky. Media relations teams that once celebrated equity-focused breakthroughs now decline interview requests with a simple refusal: "We do not have anyone for you on this."
The irony is sharp. The disparities that prompted this work have not disappeared. Boston still has a 23-year life expectancy gap between the predominantly white Back Bay and the majority-Black Roxbury. Black, Latino, Indigenous, and Pacific Islander communities continue to suffer higher rates of diabetes, hypertension, and COVID-related deaths. Disabled people and LGBTQ+ communities still face formidable barriers to adequate care. These gaps are not new—they have been embedded in Boston's geography and institutions for decades—but the pandemic made them impossible to ignore, and the policy response, however incomplete, had begun to move the needle.
Dr. Rita Hamad, director of Harvard's Social Policies for Health Equity Research Center, captured the moment's peculiar tragedy: "The silver lining of the pandemic is we figured out that we really can fix our policies to best help marginalized people. Despite the things that we learned, we're rolling all that back." Some local leaders, like Dr. Bisola Ojikutu of the Boston Public Health Commission, have pledged to continue the work regardless of federal cuts, arguing that the city has the resources to weather budget losses from Washington. But others worry about the long-term cost. Beccia pointed to the dozens of grants scrubbed from the NIH website and asked a question that cuts to the heart of the matter: if the government continues terminating equity-focused funding, "we are really going to be losing a generation of scientists."
The threat is not merely to research budgets. NIH funding does not just pay for studies; it pays for the student researchers who conduct them, allowing them to meet basic needs while they learn to study health disparities. It funds the infrastructure that makes it possible for the next generation of epidemiologists, public health experts, and clinicians to ask the questions that marginalized communities need answered. Without it, the work does not simply pause. It atrophies. The knowledge that took five years to build—about how to reach vulnerable populations, how to design interventions that actually work, how to measure what matters—risks being lost to a political moment that has decided such knowledge is a luxury the country cannot afford.
Citas Notables
The silver lining of the pandemic is we figured out that we really can fix our policies to best help marginalized people. Despite the things that we learned, we're rolling all that back.— Dr. Rita Hamad, director of Harvard's Social Policies for Health Equity Research Center
If we don't have information on a given community, how are we supposed to be doing more inclusive and effective public health work to address the needs of these communities?— Ariel Beccia, epidemiology instructor at Harvard Chan School of Public Health
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that researchers are scrubbing equity language from their papers if the research itself continues?
Because the language is not decoration. It's how you see the problem in the first place. If you strip out the framework that says "this disparity exists because of structural inequality," you're left with data that looks like individual outcomes, not systemic failures. The work becomes invisible to the very communities it's meant to serve.
The White House says finite resources should go to cutting-edge research, not vague social goals. How do you respond to that framing?
It's a false choice. Studying why Black residents die of COVID at higher rates than white residents is cutting-edge research. It requires epidemiology, data science, community engagement, and rigorous methodology. The only thing "vague" about it is the politics of pretending that asking "why" is less scientific than asking "what."
Some hospitals are removing gender-affirming care information from their websites. Are they actually stopping the care?
Not necessarily. But they're signaling that the care is now dangerous to advertise. That's a different kind of harm. Patients who need that care have to find it through whisper networks instead of official channels. It creates barriers that didn't exist before.
Dr. Ojikutu says Boston can weather federal cuts. Does that mean the work will continue?
It might, for institutions with deep pockets and political cover. But equity research is not just a Boston problem. It's national. If NIH funding dries up, researchers across the country lose the ability to study marginalized communities. The knowledge gap widens. And the students who would have become the next generation of health equity scientists? They go into other fields.
What's the actual human cost if this funding disappears?
Imagine you're a young epidemiologist who wants to study why Indigenous communities have higher rates of certain diseases. You can't get funded. You can't pay your rent on that research. You become a consultant for a pharmaceutical company instead. The question never gets asked. The community never gets studied. The disparity persists, but now there's no one left who knows how to measure it or address it.